Biological Products, Except Diagnostic Substances (Biotech) - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Biological industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Biological Products, Except Diagnostic Substances (Biotech) - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Biological Products, Except Diagnostic Substances (Biotech)
Corporate Insider Buy Sell Ratio (Insider Count) - Biological Products, Except Diagnostic Substances (Biotech)
Biological Products, Except Diagnostic Substances (Biotech) - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-08-27 MRNA / Moderna, Inc. 4 Klinger Shannon Thyme M - Exercise D 774
2025-08-27 MRNA / Moderna, Inc. 4 Mock James M M - Exercise D 774
2025-08-27 MRNA / Moderna, Inc. 4 Hoge Stephen M - Exercise D 1,437
2025-08-27 MRNA / Moderna, Inc. 4 Hoge Stephen F - Taxes D 24.73 -695
2025-08-27 MRNA / Moderna, Inc. 4 Mock James M F - Taxes D 24.73 -375
2025-08-27 MRNA / Moderna, Inc. 4 Klinger Shannon Thyme F - Taxes D 24.73 -375
2025-08-26 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 2.0808 -284,190
2025-08-26 RXRX / Recursion Pharmaceuticals, Inc. 4 Gibson Christopher S - Sale D 4.84 -100,000
2025-08-26 ALEC / Alector, Inc. 4 Hammond Paula S - Sale D 2.357 -14,000
2025-08-26 RXRX / Recursion Pharmaceuticals, Inc. 4 Gibson Christopher C - Conversion D 100,000
2025-08-25 TWST / Twist Bioscience Corporation 4 WERNER ROBERT F. S - Sale D 27.691 -853
2025-08-25 TECH / Bio-Techne Corporation 4 Nusse Roeland S - Sale D 56.3608 -17,040
2025-08-25 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 2.1163 -387,346
2025-08-25 TECH / Bio-Techne Corporation 4 BAUMGARTNER ROBERT V S - Sale D 56.21 -17,040
2025-08-25 TECH / Bio-Techne Corporation 4 BAUMGARTNER ROBERT V M - Exercise D 21.84 17,040
2025-08-25 TECH / Bio-Techne Corporation 4 Nusse Roeland M - Exercise D 21.84 17,040
2025-08-24 SGMO / Sangamo Therapeutics, Inc. 4 Macrae Sandy F - Taxes D 0.5863 -7,488
2025-08-24 SGMO / Sangamo Therapeutics, Inc. 4 Davis Gregory D F - Taxes D 0.5863 -723
2025-08-24 SGMO / Sangamo Therapeutics, Inc. 4 Willoughby Scott B. F - Taxes D 0.5863 -1,434
2025-08-24 SGMO / Sangamo Therapeutics, Inc. 4 Dubois-Stringfellow Nathalie F - Taxes D 0.5863 -1,792
2025-08-24 SGMO / Sangamo Therapeutics, Inc. 4 Duraibabu Prathyusha F - Taxes D 0.5863 -1,792
2025-08-22 BCDA / BioCardia, Inc. 4 Altman Peter P - Purchase D 1.83 700
2025-08-22 AGEN / Agenus Inc. 4 ARMEN GARO H A - Award D 4.52 3,619
2025-08-21 TWST / Twist Bioscience Corporation 4 Finn Patrick John S - Sale D 25.964 -1,840
2025-08-21 TWST / Twist Bioscience Corporation 4 Cho Dennis S - Sale D 25.964 -521
2025-08-21 TWST / Twist Bioscience Corporation 4 WERNER ROBERT F. S - Sale D 25.964 -238
2025-08-21 TSHA / Taysha Gene Therapies, Inc. 4 Alam Kamran S - Sale D 2.85 -54,491
2025-08-21 TWST / Twist Bioscience Corporation 4 Leproust Emily M. S - Sale D 25.964 -2,716
2025-08-21 TWST / Twist Bioscience Corporation 4 Laponis Adam S - Sale D 25.964 -918
2025-08-21 TSHA / Taysha Gene Therapies, Inc. 4 Nagendran Sukumar S - Sale D 2.85 -57,054
2025-08-21 TWST / Twist Bioscience Corporation 4 Green Paula S - Sale D 25.964 -619
2025-08-21 US3207032000 / First Light Acquisition Group, Inc. 4 Schoeneck James A P - Purchase D 2.00 75,000
2025-08-21 US3207032000 / First Light Acquisition Group, Inc. 4 Poma Eric E P - Purchase D 2.00 25,000
2025-08-21 US3207032000 / First Light Acquisition Group, Inc. 4 Jackson Andrew C. P - Purchase D 2.00 2,500
2025-08-21 US3207032000 / First Light Acquisition Group, Inc. 4 Leftwich Scott P - Purchase D 2.00 125,000
2025-08-20 HUMA / Humacyte, Inc. 4 Dougan Brady W By Ayabudge LLC S - Sale I 1.58 -591,685
2025-08-20 HUMA / Humacyte, Inc. 4 Niklason Laura E By Ayabudge LLC S - Sale I 1.58 -591,685
2025-08-20 AMGN / Amgen Inc. 4 Grygiel Nancy A. S - Sale D 296.985 -1,267
2025-08-19 IVVD / Invivyd, Inc. 4 Allen Robert D. III S - Sale D 0.5666 -27,420
2025-08-19 IVVD / Invivyd, Inc. 4 Andersen Jill S - Sale D 0.5666 -49,402
2025-08-19 IVVD / Invivyd, Inc. 4 Lee Timothy Edward S - Sale D 0.5666 -29,643
2025-08-19 IVVD / Invivyd, Inc. 4 Green Julie S - Sale D 0.5666 -29,643
2025-08-19 IVVD / Invivyd, Inc. 4 Duke William E. S - Sale D 0.5666 -29,643
2025-08-19 HUMA / Humacyte, Inc. 4 Dougan Brady W By Ayabudge LLC S - Sale I 1.63 -1,100,000
2025-08-19 HUMA / Humacyte, Inc. 4 Niklason Laura E By Ayabudge LLC S - Sale I 1.63 -1,100,000
2025-08-18 AURA / Aura Biosciences, Inc. 4 Elazzouzi Amy S - Sale D 6.70 -7,722
2025-08-18 IVVD / Invivyd, Inc. 4 Andersen Jill S - Sale D 0.6502 -33,352
2025-08-18 IVVD / Invivyd, Inc. 4 Green Julie S - Sale D 0.6502 -20,013
2025-08-18 ATRA / Atara Biotherapeutics, Inc. 4 Grant-Huerta Yanina S - Sale D 11.613 -86
2025-08-18 ATRA / Atara Biotherapeutics, Inc. 4 Grant-Huerta Yanina S - Sale D 11.614 -1,668
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)